CAMK2G and cardiac hypertrophy: No changes in CaMKII and calcineurin activities, Ca2+-dependent pathways involved in the pathogenesis of cardiac hypertrophy, as well as their targets (RyR and PLB phosphorylation states) were found after TAC in both conditions (Figure XVb through XVe in the online-only Data Supplement).